Upstream Bio (UPB) Assets Average (2024 - 2026)

Upstream Bio's Assets Average history runs 3 years deep, the most recent figure standing at $335.9 million for Q1 2026.

• On a quarterly basis, Assets Average fell 28.37% year-over-year to $335.9 million in Q1 2026; TTM through Mar 2026 was $335.9 million, a 28.37% decrease from a year earlier, with the FY2025 full-year figure at $417.7 million, up 39.5% from the prior year.
• Assets Average retreated to $335.9 million in Q1 2026 per UPB's latest filing, from $372.5 million in the prior quarter.
• Across five years, Assets Average topped out at $468.9 million in Q1 2025 and bottomed at $335.9 million in Q1 2026.
• The 3-year median for Assets Average is $389.2 million (2025), against an average of $396.5 million.
• Across the five-year window, Assets Average rose 4.28% in 2025 and fell 28.37% in 2026, its largest moves.
• Year by year, Assets Average stood at $357.2 million in 2024, then grew by 4.28% to $372.5 million in 2025, then decreased by 9.82% to $335.9 million in 2026.
• Per Business Quant, the three latest UPB Assets Average figures stand at $335.9 million (Q1 2026), $372.5 million (Q4 2025), and $405.9 million (Q3 2025).